滝山由美

タキヤマユミ | Takiyama Yumi

所属機関・部署：
職名：准教授

研究分野 (1件)：代謝、内分泌学

研究キーワード (1件)：糖尿病腎症

競争的資金等の研究課題 (3件)：

2022 - 2025 糖尿病循環障害:血流動態的変動指標の確立
2019 - 2022 糖尿病腎症Fast Decliner:胎内栄養環境説
2015 - 2018 Metallothionein3の糖尿病性腎症における役割の解明

論文 (22件)：

Ryoichi Bessho, Yumi Takiyama, Takao Takiyama, Hiroya Kitsunai, Yasutaka Takeda, Hidemitsu Sakagami, Tsuguhito Ota. Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy. Scientific reports. 2019. 9. 1. 14754-14754
Takiyama Y, Sera T, Nakamura M, Ishizeki K, Saijo Y, Yanagimachi T, Maeda M, Bessho R, Takiyama T, Kitsunai H, et al. Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8. EBioMedicine. 2018. 36. 329-346
Tsuyoshi Yanagimachi, Yukihiro Fujita, Yasutaka Takeda, Jun Honjo, Hidemitsu Sakagami, Hiroya Kitsunai, Yumi Takiyama, Atsuko Abiko, Yuichi Makino, Timothy J. Kieffer, et al. Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects. MOLECULAR METABOLISM. 2017. 6. 2. 226-231
Kuralay Atageldiyeva, Yukihiro Fujita, Tsuyoshi Yanagimachi, Katsutoshi Mizumoto, Yasutaka Takeda, Jun Honjo, Yumi Takiyama, Atsuko Abiko, Yuichi Makino, Masakazu Haneda. Sodium-Glucose Cotransporter 2 Inhibitor and a Low Carbohydrate Diet Affect Gluconeogenesis and Glycogen Content Differently in the Kidney and the Liver of Non-Diabetic Mice. PLOS ONE. 2016. 11. 6. e0157672.
Yukihiro Fujita, Tsuyoshi Yanagimachi, Yasutaka Takeda, Jun Honjo, Yumi Takiyama, Atsuko Abiko, Yuichi Makino, Masakazu Haneda. Alternative form of glucose-dependent insulinotropic polypepide and its physiology. JOURNAL OF DIABETES INVESTIGATION. 2016. 7. 33-37

MISC (12件)：

Takao Takiyama, Ryoichi Bessho, Kazuki Sawamoto, Yumi Takiyama. Maternal Overnutrition Causes DNA Alkylation in Fetal Liver, Suppresses FasL, and Upregulates HIF-1 Signaling Pathway in Neonatal Liver in Nonalcoholic Steatohepatitis (NASH)-Based Hepatocellular Carcinoma in Offspring. DIABETES. 2020. 69
Ryoichi Bessho, Yumi Takiyama, Manami Maeda, Kuralay K. Atageldiyeva, Yukihiro Fujita, Masakazu Haneda. Zinc; HIF-1 Mimetic in Human Renal Proximal Tubular Cells. DIABETES. 2016. 65. A137-A137
Yumi Takiyama, Manami Maeda, Kuralay K. Atageldiyeva, Tsuyoshi Yanagimachi, Jun Honjo, Yukihiro Fujita, Atsuko Abiko, Masakazu Haneda. A New Player in Diabetic Nephropathy: Metallothionein 3 Is a Target for Hypoxia Inducible Factor-1. DIABETES. 2015. 64. A142-A142
Y. Takiyama, M. Maeda, K. K. Atageldiyeva, T. Yanagimachi, J. Honjo, Y. Fujita, Y. Makino, M. Haneda. Zinc exerts anti-fibrotic action by inhibiting TGF-beta1-induced type I collagen and fibronectin in human renal proximal tubular cells. DIABETOLOGIA. 2014. 57. S480-S480
Yumi Takiyama, Ryoichi Bessho, Manami Maeda, Kuralay K. Atageldiyeva, Tsuyoshi Yanagimachi, Jun Honjo, Yukihiro Fujita, Yuichi Makino, Masakazu Haneda. SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes. DIABETES. 2014. 63. A136-A136

学位 (1件)：

医学博士 (旭川医科大学)

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

滝山 由美

滝山由美